There is a tremendous ignorance about real world realities of LMIC
Amongst HIC partners. I was interested (amused?) To see a survey yesterday in C4K asking how often we used MIBG scans to assess neuroblastoma response. The MIBG conjugated radioisotope for imaging is virtually unavailable in India so everyone uses PET-CT scanning. Our colleagues in Armenia send their patients to Russia if they really yearn for an MIBG scan. And I think the same story plays out across many LMIC and there are countries where even PET-CT scan is an unaffordable luxury. Part of me is glad we are trying to understand these real world issues, but why has it taken till 2021 to do so?